The Cutaneous Medicine theme builds on the established translational work of the St. John’s Institute by developing novel therapies and diagnostic assays for both common and potentially fatal skin conditions.

Areas of focus

Cluster One – Experimental Medicine and Therapeutics:

  • Develop novel cell therapy approaches for genetic skin disease
  • Discover and validate novel cancer specific antibodies for diagnosis and treatment of melanoma

Cluster Two – Biomarkers, Co-Diagnostics, Imaging and Devices:

  • Identify and validate novel biomarkers for inflammatory skin disease